Buscar
Mostrando ítems 71-80 de 1436
Virus–host interplay in hepatitis B virus infection and epigenetic treatment strategies
(WileyFederation of European Biochemical SocietiesGrupo de GastrohepatologíaOxford, Inglaterra, 2021)
Avances Científicos
(2018)
Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y VenezuelaEpidemiology, Use of resources, and Costs of Medical Management of Hepatitis C in Argentina, Colombia, Uruguay, and Venezuela
(Elsevier, 2019-12)
Objective: To describe the epidemiology, the consumption of resources and the relevant costs in the management of hepatitis C in four Latin American countries: Argentina, Colombia, Uruguay and Venezuela. Study design: ...
Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina
(Society for General Microbiology, 2020-11)
Introduction. Blood-borne infections are a major cause of harm in individuals on haemodialysis (HD). In particular, knowledge about hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) status in HD ...
Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV
(Taylor & Francis, 2014-02)
Chronic HCV infection affects 130-170 million individuals worldwide and there are currently 34 million people living with HIV/AIDS. The aim of treatment of HCV is the elimination of the virus (sustained virological response). ...
Hepatitis BHepatitis B
(Editora Médica ColombianaGrupo de GastrohepatologíaMedellín, Colombia, 2023)
Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
(John Wiley & Sons Inc, 2019-03-04)
Hepatitis C virus (HCV) infection is a global health concern with an estimated worldwide disease prevalence rate of 1%, meaning 71 million individuals are infected.1 In the United States, the estimated prevalence rate is ...